https://nsc693627inhibitor.com..../inter-versus-intram
Bone marrow mesenchymal stem cells (BMSCs) transplantation treatment providing a good hope for the data recovery of myocardial ischemic hypoxic injury. But, the microenvironment after myocardial damage is not conducive to the survival of BMSCs, which limits the therapeutic application of BMSCs. Our past research has actually verified that the success of BMSCs cells in the glucose and serum deprivation under hypoxia (GSDH) is increased after Andrographolide (AG) pretr
Like
Comment
Share
